Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sedation and Physiological Effects of Intranasal Dexmedetomidine in Severe COPD

NCT02211118 is registered in ClinicalTrials.gov with Dayton VA Medical Center as lead sponsor.

NCT NCT02211118
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02211118 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sedation and Physiological Effects of Intranasal Dexmedetomidine in Severe COPD
Lead sponsor
Dayton VA Medical Center
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2014
Completion date
April 30, 2016
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

copd, dexmedetomidine, sedation